Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
... and purified a 65-kDa protein from baboon kidney that had all the properties expected for the RNA-binding subunit. 3,4 The protein was purified over 140,000-fold, and silver staining of the final purified fraction showed the presence of a single protein of 65 kDa. ...... colleagues. 4 HEK293 cells are human embryonic kidney cells that have been transformed by sheared Ad5 DNA. 5 The cells contain and express the transforming genes of Ad5, including E1, which complements the deleted E1 gene from the pAdEasy-1 vector for assembly of replica...Tissue Specificity for Mutation Parallels Tissue Specificity for Cancer
...P. The mutant frequency increasedmarginally in the kidney and liver (approximately 50%) but not the stomach....from that of untreated animals,while that from the kidney included unique deletions of single GC base pairs.Thus, in this case, TDBP-specific mutations were i...Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
... Human 293 T: Embryonal kidney 721.174: EBV transfected B-cell line 721.221: EBV transfected B-cell line 721.221: EBV transfected B-cell line 721.82: EBV transfected B-cell line HeLa: Ce...Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
... Human 293 T: Embryonal kidney 721.174: EBV transfected B-cell line 721.221: EBV transfected B-cell line 721.221: EBV transfected B-cell line 721.82: EBV transfected B-cell line HeLa: Ce...... Cell line 293 T, human embryonal kidney Transfection with Plasmid pEGFP-N1 (in bidistilled H 2 O) Electroporation buffer Eppendorf Hypoosmolar Electroporation Buffer (PH) Culture medium ...... Cell line COS-1, monkey, kidney Transfection with Plasmid pEGFP-N1 (in bidistilled H 2 O) Electroporation buffer Eppendorf Hypoosmolar Electroporation Buffer (PH) Culture medium ...... Cell line COS-7, monkey, kidney Transfection with Plasmid RSV/lacZ (in bidistilled H 2 O) Electroporation buffer Eppendorf Hypoosmolar Electroporation Buffer (PH) Culture medium ...RNeasy Protect Mini, Midi, and Maxi Kits
... RNA was isolated from fresh rat kidney samples after 0, 5, 10, 15, 30, and 60 minutes, using either standard procedures (left panel) or RNeasy Protect Kits (right panel). The RNA isolated was analyzed by agarose gel electrophoresis and expression of GAPDH was examined us......ic receptor P2X3 in membrane preparations of kidney cells is demonstrated using a fully integrated 2D LC-MS/MS system to detect and quantify ICAT-labeled tryptic peptides. Optimization of ICAT procedures, by removal of the need for off-line ion exchange (IEX) and affinity clean-up af......he analysis(15 specific for kidney, 1 specific for kidney and liver, 18specific for liver, and 23 specific for brain) together with11 housekeeping genes. The chips were hybridized induplicate. The mean average signal intensity after localbackground correction and normalization between thetissues via houseke...A Better Way to Isolate RNA AND Protein From the Same Sample
... Isolation from ~30 mg of mouse liver, brain or kidney 5 days after collection. Samples were either kept frozen at -80C, stored in RNAlater at 4C, or snap frozen and then stored in RNAlater-ICE at -20C. (B) Isolation from 106 HeLa cells freshly harvested, kept 2 days in ...... specificity, miR-16 miRNA was detected in mouse kidney total RNA using three different ... 1 g of FirstChoice Total RNA from mouse kidney and 32 nt long probes generated with the mir Vana miRNA Probe Construction Kit. mir-16 mut ...New Tools for Small RNA Analysis
...or 4 g of FirstChoice Total RNA from mouse kidney included in the mir Vana miRNA Detection Kit using the indicated DNA or RNA probes included in the mir Vana miRNA Probe Construction Kit (IVT probes) or mir Vana Probe & Marker Kit (5' end labeled probes). ...Optimum FFPE RNA Isolation Kit
...E and corresponding frozen human kidney tissues are comparable. The generally acceptable r...Frozen and FFPE Human Kidney Tissues. The kidney tissue sample was divided into two sections. One section was frozen and embedded in OCT. The...Isolate It All: siRNA miRNA Total RNA Native Protein
...rocedure was performed with mouse brain or kidney that were stored for several months in <A ...ted from RNA later -treated mouse brain or kidney (~50 mg) with the mir Vana PARIS Kit (A) 1 g of each fraction was resolved on a 15% ...MessageAmp II: Use Less RNA for Array Analysis
...t significantly increase aRNA yield. Also, kidney RNA, which generally produces less aRNA than other tissues, does not produce proportional increases in aRNA yield with increasing amounts of input RNA up to above 1 g. Figure 1 also provides a useful benchmark for understandin...Hands-free Tissue Disruption No Homogenization Needed
...l RNA was isolated from fresh mouse liver, kidney and brain tissue (~7 mg processed/reaction) ... was isolated from duplicate fresh mouse liver and kidney tissues as well as from fresh and frozen mouse brain tissue, using the two isolation ...High Throughput RNA Isolation for High Performance Microarray Analysis
... Total RNA isolated from mouse kidney using MagMAX-96 for Microarrays or the Aff...Microarrays Kits. RNA, isolated from frozen mouse kidney (1 g, each sample), was amplified using MessageAmp II-96 aRNA Amplification Kit. The...Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells
... Hybrid, rat/mouse, MEL cells Monkey, kidney (COS-1, COS-7, CV-1, Vero) Mouse, 3T3, embryo Mouse, 32d, myeloma Mouse, B Mouse, BALB/c 3T3, clone A31, fibroblast, embryo Mouse, BbSutA, hematopoietic Mouse, C127, fibroblast, mammary......on, and apoptosis. In this application, human T293 kidney epithelial cells were activated with TGF-β and harvested at different time points. Lysates of these cells were prepared, run on gels, transferred to Hybond membranes, and then blotted according to the protocol previously described. The targeted ...Detection and quantitation of low-abundant proteins with ECL Plex fluorescent Western blotting
...rylation of p38, measured in human T293 epithelial kidney cells, showed proportional increase when compared and quantitatively related to actin (Fig 4). <P > <P > Conclusions Western blotting is a well-established technique. The most common application is b...... MATERIALS AND METHODS Human embryonic kidney 293 cells (HEK-293) were transiently transfected with a wild-type GFP expression plasmid (pS65T, Clontech, discontinued product; cytomegalovirus immediate early promoter drives expression of GFP) using Lipofectamine as per manufacturer's instructions...... were transiently transfected into human embryonic kidney cells (HEK-293) at non-optimal conditions; specifically the cells were seeded at modest over-confluence at the time of transfection. Subsequently, these cells were tested with the Calcium 3 no-wash reagent to measure agonist-stimulated calcium signal...Gq-coupled Receptor Assays Using FLEXstation
... from the highly differentiated Madin-Darby canine kidney epithelial cell line MDCK-D1 (1, 9). The cP2Y 11 gene was cloned into the retroviral expression vector pLXSN, which was used to transfect PA317 retroviral packing cells. The resulting virus was used to infect the canine thymocyte cell line CF2Th. In...The Genesis of Gendicine: The Story Behind the First Gene Therapy
...ll line that was subcloned fromthe human embryonic kidney (HEK) cellline 293. Gendicine is a sterile, slightlywhite-to-clear liquid. A Gendicine vialcontains 1 x 1012 viral particles in 1 mL ofWFI (water for injection) buffered with Tris(made by Amresc) and glycerol. We store itfrozen in a single-use vial a...Deltanoid Pharmaceuticals begins phase II osteoporosis study
...immune diseases, cancers, and the bone diseases of kidney failure....Biotech with Madison ties raises $21M in capital
... clinical trials on drug compounds for the chronic kidney disease (CKD) market, primarily addressing problems caused by vitamin D deficiency in kidney patients. This new financing will allow Cytochroma to achieve key milestones in the advancement of ...Madison life-science firms agree to co-develop kidney product
...and market products to treat patients with chronic kidney disease. Cytochroma, Inc. and aOvaTechnologies,...ry goal in the management of patients with chronic kidney disease is to maintain serum phosphorus levels within normal limits. Under the terms of the agreeme...Renovar captures $1.2M for product development
...y-stage company developing diagnostics to test for kidney disease is preparing to use $1.22 million in priv...oduct candidate, a urine-based assay, or test, for kidney transplant patients, is designed to better predict the possibility of rejection. It is based on the ...Technology played key role in E. coli alerts
...d the elderly are more likely to develop a form of kidney failure called hemolytic uremic syndrome (HUS), which can lead to serious kidney damage or death....Medical College receives $11 million grant to study high blood pressure
... 13 have on salt-sensitive high blood pressure and kidney failure. According to the institute, high blood pr...omosome 13, impact salt-sensitive hypertension and kidney dysfunction. This initial project also will study the genetic and physiologic reasons for gender dif...Genzyme sues former Bone Care employees
...nts on dialysis and in the early stages of chronic kidney disease. As part of a merger, Genzyme purchased BCI last July for an estimated $600 million. The former employees, Charles Bishop, Keith Crawford and Eric Messner, left Genzyme and started a new company called Proventiv Therapeutics, LLC, in Septemb...Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
...the company to pursue opportunities in the chronic kidney disease (CKD) market, including psoriasis, cancer, vitamin D deficiency, and related disorders. The combined business will have 30 employees and multiple lead candidates in clinical development for psoriasis, and it is entering clinical development...Wisconsin investors the lifeblood of New Jersey biotech
...dergo clinical trials for the support of heart and kidney harvesting, transporting, and re-implantation. The...ts support the ability to have a readily available kidney through an organ bank network, a kidney that has been properly screened for cross matching and teste...Medical College researchers win federal grants
... to research links between high blood pressure and kidney disease. Getting personal Researcher Michael St...tute to study the impact of high blood pressure on kidney injury. Cowley, the principal investigator, will use the grant to explore the consequences of eleva...Doyle laments lack of progress on stem cell bill
...uch as cancer, Parkinson's, Alzheimer's, diabetes, kidney disease, and multiple sclerosis....Wisconsin companies on the front lines in the war against cancer
...ia, lymphoma, melanoma and cancers of the thyroid, kidney and esophagus in all Americans. However, it also noted that cancer treatment is improving saving lives and extending survival for people with cancers at many sites Wisconsin bioscience companies are a part of this revolution. Here are a few exampl...Five technology companies qualify for investor tax credits
...Established in 1999 to diagnose, monitor and treat kidney transplants. For more information, visit www.renovarinc.com . Semba, Inc., Stoughton, Dane County. Founded in 2005 to produce a liquid separation device for drug discovery and development. For further information on the Angel Investor and Ventur...Cellular Dynamics getting $2 million in Wisconsin financing
...lls for hERG screening. HEK cells are derived from kidney cells that have been modified to hve some of the electrical conductivity properties of human heart cells. Market demand exists Seay said the has determined sufficient market demand for the service, while Thomson predicted the company would be the f...Genzyme acquistion of Bone Care approved, significant impact forecast
...n patients on dialysis and early stages of chronic kidney disease. Hectorol will be added to Genzyme's renal line of products for treating chronic kidney diseases, joining the phosphorous-controlling drug Renagel. A combined sales force of Genzyme and Bo...FTC has fast-tracked Bone Care merger
...ervices are focused on rare inherited disorders, kidney disease, orthopedics, cancer, transplant and imm...idism in patients with moderate to severe chronic kidney disease and end-stage renal disease. In addition to chronic kidney disease, the company is developi...Bone Care expands patent protection of core drug offering
...erapy treatment for hyperparathyroidism in chronic kidney disease patients, as well as the new version of He... make drugs that treat the side effects of chronic kidney disease, such as the overactivity of the parathyroid glands. Founded in 1987 as a research and devel...Massachusetts firm to buy UW spinoff Bone Care for $600 million
...ndary hyperparathyroidism in patients with chronic kidney disease. While Genzyme's Renagel product has gained substantially in the market sales were up 19 percent in the first quarter compared to a year ago it is primarily used for late-stage patients already on dialysis. Hectorol, which is available bot...Bone Care marks solid quarter on Hectorol sales jump
...ls of parathyroid hormone in patients with chronic kidney disease. Gross margins run about 75 percent. The company had a marked increase in profitability from the same quarter last year, when it reported losses of $2.3 million on $11.6 million in sales. Bone Care said it has $119 million in cash and inves...Attempt to exclude stem cell companies from tax credit bill hurts Wisconsin
...loping and providing stem cell and human embryonic kidney (HEK-cell) based screening services to the pharmaceutical and biotechnology industries. These services will assist in the development of safer and more effective drugs. It sends a chilling message to researchers and entrepreneurs when lawmakers who ...Cellular Dynamics hits market with UW research heavyweights
...ective drugs, using stem cells and human embryonic kidney (HEK) cells. "I've always been very proud of how strongly associated Wisconsin has become with the stem-cell field," Thomson said in a release. "There is a tremendous opportunity for this field to benefit Wisconsin economically. But we face stiff co......ctorol, which the FDA approved this April to treat kidney disease. Modine extends contract to develop CO2 coolants Modine Manufacturing Company announced on Thursday that it has a contract the U.S. Army to continue its development of alternative HVAC systems. The systems use transcritical carbon dioxid...Wisconsin publicly traded biomedical companies report gains this quarter
...ol, a Vitamin D based treatment for severe chronic kidney disease and end-stage renal disease. In April the FDA approved the drug, which is named after discoverer Hector DeLuca, a professor whose work is licensed through the Wisconsin Alumni Research Foundation . Hectorol sales for the quarter were at an ...An entrepreneurial success story Frank Langley champions biocapitalism
...od-based products for supporting heart, liver, and kidney transplants. In 1982, Pel-Freez moved to Milwaukee...ome success selling products for heart, liver, and kidney transplants, its new president saw a demand for products and services related to molecular biology. ...Mirus receives $1.26 million SBIR grant to combat anemia
...ed with serious medical conditions such as cancer, kidney failure and AIDS. Mirus delivery platform, Pathway IV, injects molecules of DNA into the body that carry genetic instructions to produce erythropoietin, or EPO, proteins, which help increase the volume of red blood cells. Once the EPO enters muscle ...The birth of biotech: San Francisco, Boston, Geneva or Chicago?
...nvestigate other aspects of EPO and focused on the kidney cells that produce EPO. While Amgen continued to support his lab at the rate of about $30,000 per year, the NIH lost interest in his work. As Goldwasser never patented any of his work, his financial share of Amgens successful sales of EPO never mate...BoneCare doubles options and profits as fiscal year closes
...idisma condition that causes patients with chronic kidney disease to suffer organ damage and bone lossthe drug has recently been converted to a half-microgram capsule so it can be provided to patients not yet on dialysis. Expanding into this market provides a huge boost, opening the drug's use to at least 8...DeLuca speaks out on entrepreneurialism, tech transfer, and WARF
...e Zemplar uses vitamin D to assist patients facing kidney dialysis and renal failure. "It's currently WARF's best earner," DeLuca said. Andy Cohn, WARFs spokesman, was unable to confirm this statement, but he did say, "Zemplar is important to WARF." DeLuca is pleased with the service he has received from...FDA approves Bone Cares Hectorol for treatment of kidney disease
... earlier stages (stages three and four) of chronic kidney disease (CKD). Current therapies for SHPT are primarily targeted for use in the more than 300,000 dialysis (stage five CKD) patients in the United States. However, this disease frequently develops during the earlier stages of CKD, before patients re...Americas weighty problem: Why the fight against fat is about more than just looking good
...er disabling complications, such as heart disease, kidney disease, blindness and amputations. About 222,000 Wisconsin adults were diagnosed with diabetes in 2000; experts believe another 112,000 were undiagnosed. The costs of diabetes dont stop there: Many other persons were at increased risk of undiagno...Americas Third Coast nurtures biotechnology
... novel vitamin D therapies for people with chronic kidney disease (CKD). The companys main drug, Hectorol, t...min D hormone levels are often impaired by chronic kidney disease. We have one of three products on the U.S. market, Hectorol, to treat vitamin D deficiency i......eat secondary hyperparathyroidism in patients with kidney (renal) disease, osteoporosis and psoriasis. The Company markets two FDA approved products, Hectorol(R) Injection and Hectorol(R) Capsules for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease....Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment
...uch as DP006 for psoriasis and bone loss caused by kidney failure and several other therapeutic areas such as fracture healing and cancer. Pharmaceutical companies developing drugs to treat bone degradation in dialysis patients have licensed compounds synthesized by the DeLuca Group for use. These compoun...